Overview

Domperidone in Refractory Gastroparesis

Status:
Terminated

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to prescribe oral domperidone for patients with gastroparesis who have failed or suffered adverse effects from standard medical therapy.

Phase:

Phase 2

Details

Lead Sponsor:

Yale University

Treatments:

Domperidone